ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Should We Worry About Covid-19 Infection in Pediatric SOT?

U. Ekong1, S. Paul1, S. Royal2, J. Chahine3, N. Yazigi1, S. Kaufman1, K. Khan1, C. Matsumoto1, A. Kroemer1, T. Fishbein1

1Surgery, Medstar Georgetown Transplant Institute, Washington, DC, 2Pediatrics, Medstar Georgetown University Hospital, Washington, DC, 3Pathology and Laboratory Medicine, Medstar Georgetown University Hospital, Washington, DC

Meeting: 2021 American Transplant Congress

Abstract number: 638

Keywords: Infection, Intestinal transplantation, Liver transplantation, Pediatric

Topic: Clinical Science » Biomarkers, Immune Assessment and Clinical Outcomes

Session Information

Session Name: Biomarkers, Immune Assessment and Clinical Outcomes

Session Type: Poster Abstract

Session Date & Time: None. Available on demand.

Location: Virtual

*Purpose: We describe the clinical presentation & immune response to COVID-19 infection in pediatric SOT.

*Methods: Medical records of COVID-19 PCR+ or seropositive patients were reviewed for details of their disease course. Blood was obtained during PCR or seropositivity for immunophenotyping & PlexCOVID-19 test. PlexCOVID-19 measures frequencies of spike Ag reactive T cells that express CD154. A pre-established algorithm predicts likelihood of COVID-19 severity. Controls were peds SOT patients with negative COVID-19 status. RNA isolated from liver tissue for PCR using the Lyra SARS CoV-2 Assay. As induction of immunological memory is central to anti-pathogen adaptive immunity induced by infection, IHC of liver tissue for tissue resident memory cells (TRM) (defined as CD69+ expressing CD4 or CD8 T cells) was performed.

*Results: 4 patients had COVID-19 & 5 patients were seropositive between March & Nov 2020 (Table 1). The 2 symptomatic PCR+ patients were hospitalized for 24-48-hours & the symptomatic seropositive patient had a prolonged PICU stay. Steroid was discontinued in 1 symptomatic PCR+ patient; & target CNI goal & steroid dose decreased in the symptomatic seropositive patient due to concurrent BK viremia. 8 patients remain well at home. Histology on 1 symptomatic PCR+ patient with elevated LFT’s revealed lymphocytic portal inflammation & SARS CoV-2 PCR on the liver was negative; histology on 1 asymptomatic seropositive patient was normal. Infrequent TRM were seen on liver biopsies but were increased in PCR+ & seropositive biopsies vs. biopsies from same patients that pre-date a COVID-19+ status. CD4+ T cells in PCR+ & seropositive patients had a phenotype consistent with activation, including expression of HLA-DR (p = 0.008); Further, BST2 was constitutively expressed on a subset of CD4+ T cells in PCR+ patients reflecting a history of IFN-alpha induced signals (p=0.01). The frequencies of spike Ag-reactive CD3 (0.95 ± 0.35 vs 2.73 ± 0.35, p= 0.037) and CD8 cells (1.10 ± 0.70 vs 5.03 ± 0.80, p= 0.034) were lower in symptomatic PCR+ patients compared with asymptomatic seropositive subjects.

*Conclusions: A small number of our SOT patients had mild or asymptomatic COVID-19 infection, with notable activation of CD4+ T cells, & constitutive expression of BST2 reflecting IFN-alpha induced signals. Spike-antigen-reactive T-cells was lower during symptomatic vs. asymptomatic infection.

 border=

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Ekong U, Paul S, Royal S, Chahine J, Yazigi N, Kaufman S, Khan K, Matsumoto C, Kroemer A, Fishbein T. Should We Worry About Covid-19 Infection in Pediatric SOT? [abstract]. Am J Transplant. 2021; 21 (suppl 3). https://atcmeetingabstracts.com/abstract/should-we-worry-about-covid-19-infection-in-pediatric-sot/. Accessed May 16, 2025.

« Back to 2021 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences